India to United Arab Emirates: Adalimumab Export Trade Route
India has recorded 4 verified shipments of Adalimumab exported to United Arab Emirates, representing a combined trade value of $64.6K USD. This corridor is served by 3 active Indian exporters, with an average shipment value of $16.1K USD. The leading Indian exporter is ANR HEALTH CARE PRIVATE LIMITED, which accounts for 96% of total export value with 1 shipments worth $62.0K USD. On the buying side, DAWAA DRUG STORE LLC is the largest importer in United Arab Emirates with $62.0K USD in purchases. The top 3 suppliers — ANR HEALTH CARE PRIVATE LIMITED, SPECIALITY PHARMA, PRANONNE HEALTH CARE — together control of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United Arab Emirates Adalimumab corridor is one of India's established pharmaceutical export routes, with 4 shipments documented worth a combined $64.6K USD. The route is dominated by ANR HEALTH CARE PRIVATE LIMITED, which alone accounts for roughly 96% of all export value, reflecting the consolidated nature of India's adalimumab manufacturing sector.
Across 3 active suppliers, the average shipment value stands at $16.1K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 77% of all shipments, consistent with adalimumab's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 18 days port-to-port. The route has recorded an annual growth rate of 10.6%, placing it at rank #19 among India's top adalimumab export destinations globally.
On the import side, key buyers of Indian adalimumab in United Arab Emirates include DAWAA DRUG STORE LLC, IMAD SOUHEIL ANDRAOS, DASUN CHATHURADHA. DAWAA DRUG STORE LLC is the single largest importer with 1 shipments valued at $62.0K USD.
